BioArctic AB's (publ) (STO: BIOA B) partner Eisai announced today that the supplemental Biologics License Application (sBLA) for Leqembi Iqlik subcutaneous autoinjector (SC-AI) as a weekly starting ...
An international research team led by The University of Osaka has demonstrated that two-faced Janus nanoparticles can restore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results